Search Results - "TOBERY, Steven A"
-
1
The capsule of Bacillus anthracis protects it from the bactericidal activity of human defensins and other cationic antimicrobial peptides
Published in PLoS pathogens (29-09-2022)“…During infection, Bacillus anthracis bacilli encounter potent antimicrobial peptides (AMPs) such as defensins. We examined the role that B . anthracis capsule…”
Get full text
Journal Article -
2
Formaldehyde and Glutaraldehyde Inactivation of Bacterial Tier 1 Select Agents in Tissues
Published in Emerging infectious diseases (01-05-2019)“…For safety, designated Select Agents in tissues must be inactivated and viability tested before the tissue undergoes further processing and analysis. In…”
Get full text
Journal Article -
3
Exposure to Bacillus anthracis capsule results in suppression of human monocyte-derived dendritic cells
Published in Infection and immunity (01-08-2014)“…The antiphagocytic capsule of Bacillus anthracis is a major virulence factor. We hypothesized that it may also mediate virulence through inhibition of the…”
Get full text
Journal Article -
4
Treatment of Experimental Anthrax with Recombinant Capsule Depolymerase
Published in Antimicrobial Agents and Chemotherapy (01-03-2008)“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text
Journal Article -
5
Burkholderia pseudomallei JW270 Is Lethal in the Madagascar Hissing Cockroach Infection Model and Can Be Utilized at Biosafety Level 2 to Identify Putative Virulence Factors
Published in Infection and immunity (18-08-2022)“…Burkholderia pseudomallei, the causative agent of melioidosis, is classified by the CDC as a tier 1 select agent, and work involving it must be performed in a…”
Get full text
Journal Article -
6
A Short Course of Antibiotic Treatment Is Effective in Preventing Death from Experimental Inhalational Anthrax after Discontinuing Antibiotics
Published in The Journal of infectious diseases (01-02-2009)“…Background. Postexposure prophylaxis of inhalational anthrax requires prolonged antibiotic therapy or antibiotics and vaccination. The duration of treatment…”
Get full text
Journal Article -
7
Clindamycin Protects Nonhuman Primates Against Inhalational Anthrax But Does Not Enhance Reduction of Circulating Toxin Levels When Combined With Ciprofloxacin
Published in The Journal of infectious diseases (03-02-2021)“…Abstract Background Inhalational anthrax is rare and clinical experience limited. Expert guidelines recommend treatment with combination antibiotics including…”
Get full text
Journal Article -
8
Comparison of three non-human primate aerosol models for glanders, caused by Burkholderia mallei
Published in Microbial pathogenesis (01-06-2021)“…Burkholderia mallei is a gram-negative obligate animal pathogen that causes glanders, a highly contagious and potentially fatal disease of solipeds including…”
Get full text
Journal Article -
9
Poly-γ-Glutamic Acid Encapsulation of Bacillus anthracis Inhibits Human Dendritic Cell Responses
Published in ImmunoHorizons (09-02-2021)“…The capsule of is composed of a d isomer poly-γ-glutamic acid polymer, which is especially nonstimulatory to dendritic cells, even more so than similar mixed…”
Get full text
Journal Article -
10
Anthrax capsule vaccine protects against experimental infection
Published in Vaccine (15-11-2004)“…Efficacy of a poly-γ- d-glutamic acid anthrax capsule vaccine was assessed in a mouse model of infection. Capsule by itself was protective against lethal…”
Get full text
Journal Article -
11
Erratum for Jelacic et al., Exposure to Bacillus anthracis Capsule Results in Suppression of Human Monocyte-Derived Dendritic Cells
Published in Infection and immunity (01-12-2014)Get full text
Journal Article